Logo image of AKZA.AS

AKZO NOBEL N.V. (AKZA.AS) Stock Fundamental Analysis

Europe - AMS:AKZA - NL0013267909 - Common Stock

60.64 EUR
-0.52 (-0.85%)
Last: 10/22/2025, 5:29:59 PM
Fundamental Rating

4

Overall AKZA gets a fundamental rating of 4 out of 10. We evaluated AKZA against 66 industry peers in the Chemicals industry. While AKZA is still in line with the averages on profitability rating, there are concerns on its financial health. AKZA has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

AKZA had positive earnings in the past year.
In the past year AKZA had a positive cash flow from operations.
Each year in the past 5 years AKZA has been profitable.
Each year in the past 5 years AKZA had a positive operating cash flow.
AKZA.AS Yearly Net Income VS EBIT VS OCF VS FCFAKZA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

Looking at the Return On Assets, with a value of 2.93%, AKZA is in the better half of the industry, outperforming 60.61% of the companies in the same industry.
The Return On Equity of AKZA (9.95%) is better than 69.70% of its industry peers.
With a decent Return On Invested Capital value of 5.84%, AKZA is doing good in the industry, outperforming 63.64% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for AKZA is in line with the industry average of 7.02%.
The last Return On Invested Capital (5.84%) for AKZA is above the 3 year average (5.38%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.93%
ROE 9.95%
ROIC 5.84%
ROA(3y)3.08%
ROA(5y)4%
ROE(3y)10.07%
ROE(5y)11.29%
ROIC(3y)5.38%
ROIC(5y)6.02%
AKZA.AS Yearly ROA, ROE, ROICAKZA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

Looking at the Profit Margin, with a value of 3.94%, AKZA is in line with its industry, outperforming 59.09% of the companies in the same industry.
AKZA's Profit Margin has declined in the last couple of years.
AKZA has a better Operating Margin (7.52%) than 60.61% of its industry peers.
AKZA's Operating Margin has been stable in the last couple of years.
AKZA's Gross Margin of 39.85% is in line compared to the rest of the industry. AKZA outperforms 57.58% of its industry peers.
AKZA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.52%
PM (TTM) 3.94%
GM 39.85%
OM growth 3Y-9.79%
OM growth 5Y-1.14%
PM growth 3Y-16.36%
PM growth 5Y-2.73%
GM growth 3Y-0.19%
GM growth 5Y-1.09%
AKZA.AS Yearly Profit, Operating, Gross MarginsAKZA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AKZA is destroying value.
AKZA has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for AKZA has been reduced compared to 5 years ago.
AKZA has a better debt/assets ratio than last year.
AKZA.AS Yearly Shares OutstandingAKZA.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
AKZA.AS Yearly Total Debt VS Total AssetsAKZA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.15 indicates that AKZA is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of AKZA (2.15) is comparable to the rest of the industry.
The Debt to FCF ratio of AKZA is 12.23, which is on the high side as it means it would take AKZA, 12.23 years of fcf income to pay off all of its debts.
AKZA has a Debt to FCF ratio (12.23) which is in line with its industry peers.
A Debt/Equity ratio of 0.88 indicates that AKZA is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.88, AKZA is not doing good in the industry: 75.76% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF 12.23
Altman-Z 2.15
ROIC/WACC0.99
WACC5.89%
AKZA.AS Yearly LT Debt VS Equity VS FCFAKZA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 1.23 indicates that AKZA should not have too much problems paying its short term obligations.
AKZA has a Current ratio of 1.23. This is amonst the worse of the industry: AKZA underperforms 80.30% of its industry peers.
AKZA has a Quick Ratio of 1.23. This is a bad value and indicates that AKZA is not financially healthy enough and could expect problems in meeting its short term obligations.
AKZA has a worse Quick ratio (0.91) than 65.15% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.91
AKZA.AS Yearly Current Assets VS Current LiabilitesAKZA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.72% over the past year.
The Earnings Per Share has been growing slightly by 4.44% on average over the past years.
Looking at the last year, AKZA shows a decrease in Revenue. The Revenue has decreased by -1.57% in the last year.
Measured over the past years, AKZA shows a small growth in Revenue. The Revenue has been growing by 2.92% on average per year.
EPS 1Y (TTM)4.72%
EPS 3Y-1.33%
EPS 5Y4.44%
EPS Q2Q%5.61%
Revenue 1Y (TTM)-1.57%
Revenue growth 3Y3.76%
Revenue growth 5Y2.92%
Sales Q2Q%-5.68%

3.2 Future

Based on estimates for the next years, AKZA will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.71% on average per year.
Based on estimates for the next years, AKZA will show a small growth in Revenue. The Revenue will grow by 1.60% on average per year.
EPS Next Y9.15%
EPS Next 2Y9.88%
EPS Next 3Y9.48%
EPS Next 5Y9.71%
Revenue Next Year-2.74%
Revenue Next 2Y-1.23%
Revenue Next 3Y0.1%
Revenue Next 5Y1.6%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AKZA.AS Yearly Revenue VS EstimatesAKZA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B
AKZA.AS Yearly EPS VS EstimatesAKZA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 16.08, which indicates a correct valuation of AKZA.
Based on the Price/Earnings ratio, AKZA is valued a bit cheaper than 68.18% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.77. AKZA is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 12.91, which indicates a correct valuation of AKZA.
72.73% of the companies in the same industry are more expensive than AKZA, based on the Price/Forward Earnings ratio.
AKZA is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.23, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.08
Fwd PE 12.91
AKZA.AS Price Earnings VS Forward Price EarningsAKZA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

AKZA's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AKZA indicates a somewhat cheap valuation: AKZA is cheaper than 71.21% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 21.7
EV/EBITDA 12.61
AKZA.AS Per share dataAKZA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

AKZA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of AKZA may justify a higher PE ratio.
PEG (NY)1.76
PEG (5Y)3.62
EPS Next 2Y9.88%
EPS Next 3Y9.48%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.24%, AKZA has a reasonable but not impressive dividend return.
AKZA's Dividend Yield is a higher than the industry average which is at 3.14.
Compared to an average S&P500 Dividend Yield of 2.36, AKZA pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.24%

5.2 History

The dividend of AKZA decreases each year by -21.52%.
Dividend Growth(5Y)-21.52%
Div Incr Years0
Div Non Decr Years4
AKZA.AS Yearly Dividends per shareAKZA.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

AKZA pays out 91.33% of its income as dividend. This is not a sustainable payout ratio.
DP91.33%
EPS Next 2Y9.88%
EPS Next 3Y9.48%
AKZA.AS Yearly Income VS Free CF VS DividendAKZA.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B
AKZA.AS Dividend Payout.AKZA.AS Dividend Payout, showing the Payout Ratio.AKZA.AS Dividend Payout.PayoutRetained Earnings

AKZO NOBEL N.V.

AMS:AKZA (10/22/2025, 5:29:59 PM)

60.64

-0.52 (-0.85%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-22 2025-07-22/bmo
Earnings (Next)10-22 2025-10-22
Inst Owners66.98%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap10.37B
Revenue(TTM)10.53B
Net Income(TTM)415.00M
Analysts77.6
Price Target71.4 (17.74%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.24%
Yearly Dividend1.98
Dividend Growth(5Y)-21.52%
DP91.33%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-5.28%
Min EPS beat(2)-6.38%
Max EPS beat(2)-4.18%
EPS beat(4)0
Avg EPS beat(4)-10.07%
Min EPS beat(4)-27.6%
Max EPS beat(4)-2.11%
EPS beat(8)1
Avg EPS beat(8)-9.19%
EPS beat(12)2
Avg EPS beat(12)-12.59%
EPS beat(16)4
Avg EPS beat(16)-10.83%
Revenue beat(2)0
Avg Revenue beat(2)-3.67%
Min Revenue beat(2)-5.13%
Max Revenue beat(2)-2.21%
Revenue beat(4)1
Avg Revenue beat(4)-2.54%
Min Revenue beat(4)-5.13%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-1.23%
Revenue beat(12)3
Avg Revenue beat(12)-1.37%
Revenue beat(16)3
Avg Revenue beat(16)-1.73%
PT rev (1m)0.9%
PT rev (3m)-0.27%
EPS NQ rev (1m)-2.11%
EPS NQ rev (3m)-7.47%
EPS NY rev (1m)-0.37%
EPS NY rev (3m)-5.2%
Revenue NQ rev (1m)-0.89%
Revenue NQ rev (3m)-4.42%
Revenue NY rev (1m)-0.29%
Revenue NY rev (3m)-3.58%
Valuation
Industry RankSector Rank
PE 16.08
Fwd PE 12.91
P/S 0.99
P/FCF 21.7
P/OCF 12.77
P/B 2.49
P/tB 27.15
EV/EBITDA 12.61
EPS(TTM)3.77
EY6.22%
EPS(NY)4.7
Fwd EY7.75%
FCF(TTM)2.79
FCFY4.61%
OCF(TTM)4.75
OCFY7.83%
SpS61.54
BVpS24.39
TBVpS2.23
PEG (NY)1.76
PEG (5Y)3.62
Graham Number45.49
Profitability
Industry RankSector Rank
ROA 2.93%
ROE 9.95%
ROCE 8.79%
ROIC 5.84%
ROICexc 7.07%
ROICexgc 14.42%
OM 7.52%
PM (TTM) 3.94%
GM 39.85%
FCFM 4.54%
ROA(3y)3.08%
ROA(5y)4%
ROE(3y)10.07%
ROE(5y)11.29%
ROIC(3y)5.38%
ROIC(5y)6.02%
ROICexc(3y)6.53%
ROICexc(5y)7.21%
ROICexgc(3y)12.06%
ROICexgc(5y)13.03%
ROCE(3y)9.71%
ROCE(5y)10.22%
ROICexgc growth 3Y-10.53%
ROICexgc growth 5Y-0.19%
ROICexc growth 3Y-9.99%
ROICexc growth 5Y-0.31%
OM growth 3Y-9.79%
OM growth 5Y-1.14%
PM growth 3Y-16.36%
PM growth 5Y-2.73%
GM growth 3Y-0.19%
GM growth 5Y-1.09%
F-Score5
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF 12.23
Debt/EBITDA 3.13
Cap/Depr 88.83%
Cap/Sales 3.17%
Interest Coverage 4.95
Cash Conversion 69.52%
Profit Quality 115.18%
Current Ratio 1.23
Quick Ratio 0.91
Altman-Z 2.15
F-Score5
WACC5.89%
ROIC/WACC0.99
Cap/Depr(3y)80.65%
Cap/Depr(5y)79.09%
Cap/Sales(3y)2.74%
Cap/Sales(5y)2.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.72%
EPS 3Y-1.33%
EPS 5Y4.44%
EPS Q2Q%5.61%
EPS Next Y9.15%
EPS Next 2Y9.88%
EPS Next 3Y9.48%
EPS Next 5Y9.71%
Revenue 1Y (TTM)-1.57%
Revenue growth 3Y3.76%
Revenue growth 5Y2.92%
Sales Q2Q%-5.68%
Revenue Next Year-2.74%
Revenue Next 2Y-1.23%
Revenue Next 3Y0.1%
Revenue Next 5Y1.6%
EBIT growth 1Y-27.93%
EBIT growth 3Y-6.39%
EBIT growth 5Y1.75%
EBIT Next Year36.41%
EBIT Next 3Y15.61%
EBIT Next 5Y12.68%
FCF growth 1Y27.47%
FCF growth 3Y4.63%
FCF growth 5YN/A
OCF growth 1Y22.84%
OCF growth 3Y3.41%
OCF growth 5Y96.16%